{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T20:30:08Z","timestamp":1722457808508},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T00:00:00Z","timestamp":1450828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0145746","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T18:45:05Z","timestamp":1450896305000},"page":"e0145746","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside\/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus"],"prefix":"10.1371","volume":"10","author":[{"given":"Xin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baosheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fubiao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwen","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Nassal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianxing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3748\/wjg.v13.i1.48","article-title":"Hepatitis B virus replication","volume":"13","author":"J Beck","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"1\u20132","key":"ref2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.virusres.2007.12.024","article-title":"Hepatitis B viruses: reverse transcription a different way","volume":"134","author":"M Nassal","year":"2008","journal-title":"Virus Res"},{"key":"ref3","unstructured":"WHO. Hepatitis B. Fact sheet no 204. 2008."},{"issue":"9959","key":"ref4","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"C Trepo","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/17474124.2014.909724","article-title":"Current developments in nucleoside\/nucleotide analogues for hepatitis B","volume":"8","author":"AO Lo","year":"2014","journal-title":"Expert review of gastroenterology & hepatology"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021501","article-title":"Antiviral Therapies and Prospects for a Cure of Chronic Hepatitis B","volume":"5","author":"F Zoulim","year":"2015","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"F Zoulim","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"M Nassal","year":"2015","journal-title":"Gut"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2012.11.039","article-title":"Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside\/nucleotide analogue therapy: finite treatment duration unlikely","volume":"58","author":"S Chevaliez","year":"2013","journal-title":"J Hepatol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2217\/17460794.4.1.55","article-title":"New insights into HBV replication: new opportunities for improved therapies","volume":"4","author":"M Nassal","year":"2009","journal-title":"Future Virology"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/135965350400900203","article-title":"Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations","volume":"9","author":"A Bartholomeusz","year":"2004","journal-title":"Antivir Ther"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1128\/JVI.75.10.4771-4779.2001","article-title":"Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC)","volume":"75","author":"K Das","year":"2001","journal-title":"J Virol"},{"issue":"15","key":"ref14","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1128\/JVI.00482-11","article-title":"A Tyr residue in the reverse transcriptase domain can mimic the protein-priming Tyr residue in the terminal protein domain of a hepadnavirus p protein","volume":"85","author":"J Beck","year":"2011","journal-title":"J Virol"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/nar\/30.7.1679","article-title":"dNTP versus NTP discrimination by phenylalanine 451 in duck hepatitis B virus P protein indicates a common structure of the dNTP-binding pocket with other reverse transcriptases","volume":"30","author":"J Beck","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1128\/JVI.00011-12","article-title":"Extensive mutagenesis of the conserved box E motif in duck hepatitis B virus P protein reveals multiple functions in replication and a common structure with the primer grip in HIV-1 reverse transcriptase","volume":"86","author":"YX Wang","year":"2012","journal-title":"J Virol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/jhep.2001.22166","article-title":"Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region","volume":"33","author":"LJ Stuyver","year":"2001","journal-title":"Hepatology"},{"issue":"3 Pt B","key":"ref18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3851\/IMP1499","article-title":"Molecular genesis of drug-resistant and vaccine-escape HBV mutants","volume":"15","author":"SA Locarnini","year":"2010","journal-title":"Antivir Ther"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrgastro.2009.107","article-title":"Hepatitis B virus variants","volume":"6","author":"W Chotiyaputta","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.22796","article-title":"Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model","volume":"49","author":"S Kamili","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/he.2000.6407","article-title":"Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays","volume":"31","author":"JH Ireland","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hep.510270138","article-title":"Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation","volume":"27","author":"U Protzer-Knolle","year":"1998","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"ref23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2893.1997.tb00155.x","article-title":"The clinical significance of surface antigen variants of hepatitis B virus","volume":"4","author":"WF Carman","year":"1997","journal-title":"J Viral Hepat"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1743-422X-10-292","article-title":"Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants","volume":"10","author":"M Zhang","year":"2013","journal-title":"Virology journal"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0168-8278(99)80213-X","article-title":"Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin","volume":"31","author":"WF Carman","year":"1999","journal-title":"J Hepatol"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1128\/JVI.01796-09","article-title":"Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains","volume":"84","author":"S Amini-Bavil-Olyaee","year":"2010","journal-title":"J Virol"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1128\/JVI.75.11.5084-5089.2001","article-title":"Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus","volume":"75","author":"J K\u00f6ck","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2005.03.090","article-title":"Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes","volume":"129","author":"D Glebe","year":"2005","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-60761-688-7_13","article-title":"The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies","volume":"640","author":"MJ Marion","year":"2010","journal-title":"Methods Mol Biol"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Y Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"H Yan","year":"2012","journal-title":"Elife"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","article-title":"Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP","volume":"443","author":"M Iwamoto","year":"2014","journal-title":"Biochemical and biophysical research communications"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/hep.510280432","article-title":"Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus","volume":"28","author":"WE Delaney 4th","year":"1998","journal-title":"Hepatology"},{"issue":"Pt 8","key":"ref34","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1099\/vir.0.83659-0","article-title":"Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector","volume":"89","author":"J Lucifora","year":"2008","journal-title":"J Gen Virol"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.23230","article-title":"Control of hepatitis B virus replication by innate response of HepaRG cells","volume":"51","author":"J Lucifora","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"MA Sells","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1743-422X-8-231","article-title":"Hepatitis B virus induces G1 phase arrest by regulating cell cycle genes in HepG2.2.15 cells","volume":"8","author":"T Wang","year":"2011","journal-title":"Virology journal"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3748\/wjg.v17.i9.1152","article-title":"Hepatoma cell line HepG2.2.15 demonstrates distinct biological features compared with parental HepG2","volume":"17","author":"R Zhao","year":"2011","journal-title":"World J Gastroenterol"},{"key":"ref39","first-page":"429","article-title":"The power of reversibility regulating gene activities via tetracycline-controlled transcription","volume":"477","author":"K Sch\u00f6nig","year":"2010","journal-title":"Methods Enzymol"},{"issue":"1","key":"ref40","first-page":"65","article-title":"The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues","volume":"9","author":"SK Ladner","year":"1998","journal-title":"Antivir Chem Chemother"},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"SK Ladner","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"22","key":"ref42","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation","volume":"81","author":"H Guo","year":"2007","journal-title":"J Virol"},{"issue":"18","key":"ref43","doi-asserted-by":"crossref","first-page":"9332","DOI":"10.1128\/JVI.00918-10","article-title":"Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus","volume":"84","author":"C Xu","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2006.05.019","article-title":"Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus","volume":"45","author":"D Sun","year":"2006","journal-title":"J Hepatol"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/JVI.01292-06","article-title":"Inhibition of alpha interferon signaling by hepatitis B virus","volume":"81","author":"V Christen","year":"2007","journal-title":"J Virol"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/JVI.02415-06","article-title":"The level of viral antigen presented by hepatocytes influences CD8 T-cell function","volume":"81","author":"AJ Gehring","year":"2007","journal-title":"J Virol"},{"issue":"14","key":"ref47","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1021\/ja809949r","article-title":"Identification of an overabundant cholesterol precursor in hepatitis B virus replicating cells by untargeted lipid metabolite profiling","volume":"131","author":"MA Rodgers","year":"2009","journal-title":"J Am Chem Soc"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.22951","article-title":"Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference","volume":"50","author":"P Bellecave","year":"2009","journal-title":"Hepatology"},{"issue":"14","key":"ref49","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.1128\/JVI.77.14.7814-7819.2003","article-title":"An infectious clone of woolly monkey hepatitis B virus","volume":"77","author":"RE Lanford","year":"2003","journal-title":"J Virol"},{"key":"ref50","article-title":"Comparative Hepatitis","author":"K Dallmeier","year":"2008"},{"issue":"12","key":"ref51","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1128\/JVI.03533-12","article-title":"Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes","volume":"87","author":"G Zhong","year":"2013","journal-title":"J Virol"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nbt1389","article-title":"Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein","volume":"26","author":"J Petersen","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"e53392","DOI":"10.1371\/journal.pone.0053392","article-title":"Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis","volume":"8","author":"J Liu","year":"2013","journal-title":"PloS one"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jhep.2009.10.038","article-title":"Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites","volume":"52","author":"D Sun","year":"2010","journal-title":"J Hepatol"},{"issue":"7","key":"ref55","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1128\/JVI.64.7.3319-3330.1990","article-title":"Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein","volume":"64","author":"F Birnbaum","year":"1990","journal-title":"J Virol"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1128\/JVI.75.3.1104-1116.2001","article-title":"Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors","volume":"75","author":"S Ren","year":"2001","journal-title":"J Virol"},{"issue":"4","key":"ref57","doi-asserted-by":"crossref","first-page":"e60306","DOI":"10.1371\/journal.pone.0060306","article-title":"Replication-competent infectious hepatitis B virus vectors carrying substantially sized transgenes by redesigned viral polymerase translation","volume":"8","author":"Z Wang","year":"2013","journal-title":"PloS one"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/135965350701200309","article-title":"In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents","volume":"12","author":"X Qi","year":"2007","journal-title":"Antivir Ther"},{"issue":"1\u20132","key":"ref59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-0934(99)00154-8","article-title":"Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR)","volume":"85","author":"KM Weinberger","year":"2000","journal-title":"J Virol Methods"},{"issue":"5739","key":"ref60","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/282575a0","article-title":"Hepatitis B virus genes and their expression in E. coli","volume":"282","author":"M Pasek","year":"1979","journal-title":"Nature"},{"issue":"1\u20132","key":"ref61","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0021-9673(94)01259-H","article-title":"Non-denaturing gel electrophoresis of biological nanoparticles: viruses","volume":"698","author":"P Serwer","year":"1995","journal-title":"J Chromatogr A"},{"issue":"3","key":"ref62","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1128\/JVI.79.3.1871-1887.2005","article-title":"Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg 165\u2013173)","volume":"79","author":"S Le Pogam","year":"2005","journal-title":"J Virol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/srep00005","article-title":"SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure","volume":"1","author":"A Walker","year":"2011","journal-title":"Sci Rep"},{"issue":"7","key":"ref64","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/JVI.66.7.4107-4116.1992","article-title":"The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly","volume":"66","author":"M Nassal","year":"1992","journal-title":"J Virol"},{"issue":"1","key":"ref65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.22295","article-title":"The antiviral drug selected hepatitis B virus rtA181T\/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound","volume":"48","author":"N Warner","year":"2008","journal-title":"Hepatology"},{"issue":"5608","key":"ref66","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.1077215","article-title":"Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids","volume":"299","author":"K Deres","year":"2003","journal-title":"Science"},{"issue":"6","key":"ref67","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jmr.801","article-title":"BAY 41\u20134109 has multiple effects on Hepatitis B virus capsid assembly","volume":"19","author":"SJ Stray","year":"2006","journal-title":"J Mol Recognit"},{"issue":"12","key":"ref68","doi-asserted-by":"crossref","first-page":"e25096","DOI":"10.1371\/journal.pone.0025096","article-title":"Antiviral activity of Bay 41\u20134109 on hepatitis B virus in humanized Alb-uPA\/SCID mice","volume":"6","author":"N Brezillon","year":"2011","journal-title":"PloS one"},{"issue":"10","key":"ref69","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1128\/JCM.00272-07","article-title":"In vitro drug susceptibility analysis of hepatitis B virus clinical quasispecies populations","volume":"45","author":"Y Zhu","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"5","key":"ref70","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2008.01.027","article-title":"Impact of hepatitis B virus rtA181V\/T mutants on hepatitis B treatment failure","volume":"48","author":"S Villet","year":"2008","journal-title":"J Hepatol"},{"issue":"6","key":"ref71","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.20723","article-title":"Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir","volume":"41","author":"MN Brunelle","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"ref72","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/jhep.2002.35070","article-title":"Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses","volume":"36","author":"B Seigneres","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"ref73","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5507\/bp.2005.049","article-title":"Cytotoxicity of pivoxil esters of antiviral acyclic nucleoside phosphonates: adefovir dipivoxil versus adefovir","volume":"149","author":"Z Zidek","year":"2005","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref74","article-title":"Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure","author":"MB Zeisel","year":"2015","journal-title":"Gut"},{"issue":"4","key":"ref75","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00430-012-0267-9","article-title":"Host factors involved in hepatitis B virus maturation, assembly, and egress","volume":"201","author":"R Prange","year":"2012","journal-title":"Med Microbiol Immunol"},{"issue":"3","key":"ref76","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hep.26125","article-title":"A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant","volume":"57","author":"C Sureau","year":"2013","journal-title":"Hepatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0145746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T16:25:21Z","timestamp":1653927921000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0145746"}},"subtitle":[],"editor":[{"given":"Haitao","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":76,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0145746","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,23]]}}}